Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling
{{output}}
This study examined rates of genetic testing in two cohorts of publicly insured individuals who have newly prescribed medication with FDA pharmacogenomic labeling guidance. Genetic testing was rare (4.4% and 10.5% in Medicaid and Medicare cohorts, respectively... ...
